申请人:MORPHOCHEM AG
公开号:US20020137687A1
公开(公告)日:2002-09-26
The present invention relates to compounds of the Formula
1
or a pharmaceutically acceptable salt, solvate, hydrate or formulation thereof. These compounds can be used for the inhibition of tryptase and for the treatment and/or prevention of diseases that are mediated by tryptase activity.
本发明涉及公式1的化合物或其药学上可接受的盐、溶剂化合物、水合物或制剂。这些化合物可用于抑制组胺酶和治疗和/或预防由组胺酶活性介导的疾病。